PROMISTO

Welcome to the Brand page for “PROMISTO”, which is offered here for Human pharmaceuticals for the treatment of infectious-related disease, auto-immune and inflammatory diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases, respiratory diseases, ophthalmic diseases, muscle dystonias, smooth muscle disorders, gastro-intestinal diseases; human pharmaceuticals for use as hemostatic agents;.

Its status is currently believed to be active. Its class is unavailable. “PROMISTO” is believed to be currently owned by “JANSSEN R&D IRELAND”.